Contract facts
FederalNO-COST REALIGNMENT OF OPTION PERIOD 2 ODCS is a federal award for Ibc Acq Svcs Directorate (00004) held by Amdex Corp. Estimated value $7.5M ($0 obligated). Current period of performance ends Sep 15, 2019 (potential Sep 15, 2021). Last award drew 5 bidders. Place of performance: WASHINGTON DC. Related solicitation D16PS00250.
NO-COST REALIGNMENT OF OPTION PERIOD 2 ODCS
Recompete timing
PublicCurrent PoP ended Sep 15, 2019 (2532 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Incumbent footprint
Public recordAmdex Corp — $7.8M obligated across 17 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract IND16PD01081?
IND16PD01081 (No-cost realignment of OPTION PERIOD 2 ODCS) is a Ibc Acq Svcs Directorate (00004) award with a potential value of $7.5M, currently held by Amdex Corp. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded IND16PD01081?
Ibc Acq Svcs Directorate (00004) awarded IND16PD01081 to Amdex Corp (potential $7.5M).
Who is the incumbent on IND16PD01081?
Amdex Corp is the incumbent with $7.8M across 17 related awards in SCOUT’s public footprint. The current period of performance ends Sep 15, 2019.
When does Amdex Corp’s IND16PD01081 come up for recompete?
SCOUT tracks a period-of-performance end of Sep 15, 2019. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.
